Eating Disorder Risk and Screening in Patients Using GLP ‐ 1RAs : Lessons Learned From Metabolic and Bariatric Surgery
International Journal of Eating Disorders · 2026-11 · 59 (11) · 2370-2374
DOI: 10.1002/eat.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Eating Disorders, online erschienen am 26.07.2026. Verfasst von Kirstie M Herb Neff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, Geisinger College of Health Sciences, Danville, Pennsylvania, USA. Hauptthemen laut MEDLINE: Bariatric Surgery, Feeding and Eating Disorders, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Novo Nordisk.
Abstract (Originalsprache)
Objective
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are increasingly prescribed for weight management. Similar to the early implementation of metabolic and bariatric surgery (MBS), little is known about how GLP‐1RAs affect individuals with eating disorders (EDs) or their potential to promote, mask, or exacerbate ED psychopathology. Lacking robust empirical data directly examining associations between GLP‐1RAs and ED risk, we draw on lessons from the field of MBS to summarize current critical knowledge gaps and guide clinicians, educators, researchers, and advocates on interim decision‐making.
Method
As providers working at the intersection of EDs and obesity treatment, we integrate published findings with our clinical and research expertise to identify potential ED risks associated with GLP‐1RA use and identify opportunities to screen and intervene.
Results
Initially in MBS practice, ED symptoms were underrecognized due to lack of standardized screening and monitoring protocols. Early concerns arose from patient reports and provider observations, followed by empirical and systematic research investigation leading to the development of structured assessment tools and protocols. Similar concerns are arising with GLP‐1RA treatment, where changes in appetite and weight may, without prospective or ongoing screening, worsen existing or contribute to de novo ED behaviors and cognitions.
Conclusion
ED providers are uniquely positioned to identify and address disordered eating occurring with GLP‐1RA treatment that may be overlooked by providers with less ED training and experience. We highlight opportunities for ED professionals to engage in advocacy, education, and interdisciplinary collaboration to reduce harm and promote patient wellbeing as GLP‐1RA use increases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Population Health Sciences, Geisinger College of Health Sciences, Danville, Pennsylvania, USA.
- Center for Obesity and Metabolic Research, Geisinger College of Health Sciences, Danville, Pennsylvania, USA.
- Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Psychiatry, University of Pittsburg School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Kirstie M Herb Neff, Ashley Dunford, Andrea B Goldschmidt, Kelly C Allison, Alexis Richeson
Förderung
- Novo Nordisk
Zitieren
APA
Herb Neff, K. M., Dunford, A., Goldschmidt, A. B., Allison, K. C., & Richeson, A. (2026). Eating Disorder Risk and Screening in Patients Using GLP ‐ 1RAs : Lessons Learned From Metabolic and Bariatric Surgery. International Journal of Eating Disorders, 59(11), 2370-2374. https://doi.org/10.1002/eat.70180
Vancouver
Herb Neff KM, Dunford A, Goldschmidt AB, Allison KC, Richeson A. Eating Disorder Risk and Screening in Patients Using GLP ‐ 1RAs : Lessons Learned From Metabolic and Bariatric Surgery. International Journal of Eating Disorders. 2026;59(11):2370-2374. doi:10.1002/eat.70180
BibTeX
@article{HerbNeff2026,
author = {Herb Neff, Kirstie M and Dunford, Ashley and Goldschmidt, Andrea B and Allison, Kelly C and Richeson, Alexis},
title = {Eating Disorder Risk and Screening in Patients Using GLP ‐ 1RAs : Lessons Learned From Metabolic and Bariatric Surgery},
journal = {International Journal of Eating Disorders},
year = {2026},
volume = {59},
number = {11},
pages = {2370--2374},
doi = {10.1002/eat.70180}
}
EUVIMED